Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR03 Tenofovir disoproxil and emtricitabine
D02297 Emtricitabine and tenofovir disoproxil <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Combinations
Emtricitabine/ Tenofovir Disoproxil Fumarate
D02297 Emtricitabine and tenofovir disoproxil
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D02297 Emtricitabine and tenofovir disoproxil
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D02297 Emtricitabine and tenofovir disoproxil
DG03107 Anti-HIV agent
D02297 Emtricitabine and tenofovir disoproxil
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D02297 Emtricitabine and tenofovir disoproxil
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D02297 Emtricitabine and tenofovir disoproxil <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02297
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02297